Pay in 4 interest-free payments of $6.20 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
doi: 10.1038/s41588-022-01254-1 61 HuangXWuLPeiTLiuDLiuCLuoBet al
The primary antibodies used were anti-4-HNE (Abcam, catalog ab4654, 1:100), anti-GPX4 (Abcam, catalog ab125066, 1:200), anti-fibronectin (Abcam, catalog ab45688, 1:100), and anti--SMA (Abcam, catalog ab124964, 1:100)
Thomsen RW, Mailhac A, Lohde JB, Pottegard A
Theoretical angiogenic risk in patients with active malignancy or high oncological risk warrants direct oncological consultation before use
US$ 25.55
US$ 29.24
US$ 20.72
US$ 24.01
US$ 28.08
US$ 28.32
